011000 — Gene One Life Science Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Gene One Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90,432	108,209	45,851	10,068	1,180
Net Total Accounts Receivable
Net Total Receivables	8,401	9,413	10,579	7,572	8,310
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	108,760	134,633	73,063	34,573	28,635
Net Property, Plant And Equipment	22,427	110,382	144,369	111,399	117,730
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	136,571	250,857	222,867	151,008	151,334
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	36,705	34,759	33,836	22,867	42,506
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	38,062	44,350	41,395	39,518	65,729
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	98,509	206,507	181,471	111,489	85,605
Total Liabilities & Shareholders' Equity	136,571	250,857	222,867	151,008	151,334
Total Common Shares Outstanding